We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$67.5M
Cap. Flow
-$16.8M
Cap. Flow %
-1.57%
Top 10 Hldgs %
43.59%
Holding
2,793
New
103
Increased
1,023
Reduced
644
Closed
145

Sector Composition

Rank Sector Weight
1 Technology 15.66%
2 Financials 13.81%
3 Healthcare 6.79%
4 Consumer Discretionary 3.87%
5 Communication Services 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWST icon
2101
Twist Bioscience
TWST
$7.25B
$2.98K ﹤0.01%
87
+48
+123% +$1.73K
FMAG icon
2102
Fidelity Magellan ETF
FMAG
$251M
$2.98K ﹤0.01%
106
+33
+45% +$866
SKY icon
2103
Champion Homes
SKY
$5.14B
$2.98K ﹤0.01%
35
RKT icon
2104
Rocket Companies
RKT
$38.9B
$2.97K ﹤0.01%
204
CRI icon
2105
Carter's
CRI
$1.47B
$2.96K ﹤0.01%
35
TLRY icon
2106
Tilray
TLRY
$622M
$2.96K ﹤0.01%
120
BALY icon
2107
Bally's
BALY
$658M
$2.96K ﹤0.01%
212
+149
+237% +$1.74K
BRY
2108
DELISTED
Berry Corp
BRY
$2.95K ﹤0.01%
366
+225
+160% +$1.57K
VTLE
2109
DELISTED
Vital Energy
VTLE
$2.94K ﹤0.01%
56
-33
-37% -$1.53K
LLYVK icon
2110
Liberty Live Group Series C
LLYVK
$9.46B
$2.94K ﹤0.01%
67
CORT icon
2111
Corcept Therapeutics
CORT
$12B
$2.92K ﹤0.01%
116
+2
+2% +$47
SEAT icon
2112
Vivid Seats
SEAT
$85.4M
$2.92K ﹤0.01%
24
-11
-31% -$1.29K
ROIV icon
2113
Roivant Sciences
ROIV
$26.2B
$2.89K ﹤0.01%
274
FBP icon
2114
First Bancorp
FBP
$4.38B
$2.88K ﹤0.01%
164
CDLX icon
2115
Cardlytics
CDLX
$21.5M
$2.87K ﹤0.01%
20
+9
+82% +$760
KREF
2116
KKR Real Estate Finance Trust
KREF
$499M
$2.87K ﹤0.01%
285
-98
-26% -$1.07K
AG icon
2117
First Majestic Silver
AG
$9.07B
$2.86K ﹤0.01%
487
-320
-40% -$1.6K
GTLB icon
2118
GitLab
GTLB
$6.58B
$2.86K ﹤0.01%
49
+45
+1,125% +$2.95K
CAMT icon
2119
Camtek
CAMT
$7.25B
$2.85K ﹤0.01%
34
NUS icon
2120
Nu Skin
NUS
$267M
$2.83K ﹤0.01%
205
-311
-60% -$4.86K
RLAY icon
2121
Relay Therapeutics
RLAY
$4.33B
$2.83K ﹤0.01%
341
-106
-24% -$1.03K
DDD icon
2122
3D Systems Corp
DDD
$613M
$2.82K ﹤0.01%
636
ERIE icon
2123
Erie Indemnity
ERIE
$13.2B
$2.81K ﹤0.01%
7
OFG icon
2124
OFG Bancorp
OFG
$2.21B
$2.8K ﹤0.01%
76
LITE icon
2125
Lumentum
LITE
$69.3B
$2.79K ﹤0.01%
59
+7
+13% +$356

Similar funds

Lindbrook Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Lindbrook Capital held 2,793 positions worth $1.07B, up 6.7% from $1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Lindbrook Capital's Q1 2024 filing shows 103 new, 1,023 increased, 644 reduced and 145 closed positions. Its largest new stake was Hess Midstream: 14,335 shares worth $518K. The largest sale was Golub Capital BDC, an estimated $15.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Lindbrook Capital's largest Q1 2024 buy was Hess Midstream: 14,335 shares worth $518K.
  • Lindbrook Capital added most to Vertex Pharmaceuticals in Q1 2024, an estimated $8.03M increase.
  • Lindbrook Capital's biggest Q1 2024 reduction was Golub Capital BDC, cutting an estimated $15.8M.
  • Lindbrook Capital fully exited Splunk Inc in Q1 2024, selling an estimated $153K.
  • Lindbrook Capital's ten largest holdings make up 44% of its $1.07B portfolio in Q1 2024.
  • Lindbrook Capital opened 103 new positions and closed 145 in Q1 2024.
  • Lindbrook Capital's portfolio value rose 6.7% quarter-over-quarter to $1.07B.

Based on Lindbrook Capital's 13F filing for Q1 2024, filed 25 Apr 2024.